If you need more lookups,
subscriptions start at $34 USD/month.
Stephen Eck Location
Cambridge, MA, US
Stephen Eck Work
Chief Medical Officer @ (January 2026 - Present)
Chief Medical Officer @ (July 2020 - January 2026)
Diagnostics @ (July 2016 - January 2026)
President and Chief Executive Officer @ Aravive Biologics, Inc. (May 2017 - July 2020)
Vice President, Oncology @ Astellas Global Pharma Development (January 2011 - March 2017)
Vice President @ Astellas Pharma (January 2011 - January 2012)
VIce President @ Eli Lilly (July 2007 - March 2011)
Vie President, Translational Medicine and Pharmacogenomics @ Eli Lilly and Company (July 2007 - March 2011)
Vice President @ (January 2002 - January 2007)
Stephen Eck Education
University of Mississippi Medical Center
Doctor of Medicine - MD (Medicine)
1982-1987
Harvard University
Doctor of Philosophy - PhD (Organic Chemistry)
1976-1981
Stephen Eck Skills
Translational Medicine
Oncology
Biomarkers
Drug Development
Clinical Trials
Pharmaceutical Industry
Biotechnology
Drug Discovery
Lifesciences
Clinical Research
Medical Affairs
Clinical Pharmacology
Pharmacology
Infectious Diseases
Cancer
CRO
Regulatory Affairs
Outcomes Research
Diabetes
GCP
Therapeutic Areas
Regulatory Submissions
Molecular Biology
CTMS
GLP
Leadership
Clinical Development
Biopharmaceuticals
Life Sciences
Pharmacovigilance
Healthcare Management
Sales
Aircraft Sales
Development
Stephen Eck Summary
Stephen Eck, based in Cambridge, MA, US, is currently a Chief Medical Officer at Flare Therapeutics. Stephen Eck brings experience from previous roles at MacroGenics, Inc., Luminex Corporation, Aravive Biologics, Inc. and Astellas Global Pharma Development. Stephen Eck holds a 1982 - 1987 Doctor of Medicine - MD in Medicine @ University of Mississippi Medical Center. With a robust skill set that includes Translational Medicine, Oncology, Biomarkers, Drug Development, Clinical Trials and more. Stephen Eck has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Stephen Eck?
Find contact details for 700 million professionals.